Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAVU Solution for Parathyroid Preservation
NCT02978287Unknown
- Sponsor
- Şişli Hamidiye Etfal Training and Research Hospital
- Start
- Sep 2016
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of BAVU solution in Parathyroid hyperplasia (PHPT) (5 arms), sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Primary endpoint: Cell viability of Parathyroid cells at 24 hours. Status: unknown.
02
Drugs
BAVU solution
03
Conditions
Parathyroid hyperplasia (PHPT)
Beyond the preview
Go deeper on NCT02978287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02978287.